IIT Kanpur is ready with an artificial heart that would be of great help to people with acute cardiac problems.
IIT Kanpur Director, Abhay Karandikar, said that the trial on animals would begin next year.
He said, "Now heart transplant will be easy. Artificial hearts can be implanted in serious patients. IIT Kanpur and cardiologists from across the country have developed this artificial heart. Trial on animals will start from February or March. After success in the trial, transplantation can be done in humans in the next two years."
Karandikar said that heart disease was increasing rapidly and a large number of patients were being advised heart transplant.
"Artificial heart is being developed to reduce the sufferings of the patients," he said, adding, "a team of 10 scientists and doctors has prepared this artificial heart. After the success of the trial on animals, heart transplantation in humans will begin within two years."
He said that doctors and scientists should together prepare equipment and implants.
He said, "India imports 80 per cent of equipment and implants from abroad. Only 20 percent of the equipment and implants are being manufactured in India. Most of the implants and stents for heart patients are being imported."
He further said, "Covid-19 taught us some hard lessons. Before Covid, ventilators were not made in India. To save the lives of corona-infected, Indian scientists and doctors prepared ventilators in just 90 days. Two companies are manufacturing ventilators in India. Foreign ventilator costs Rs 10 to 12 lakh while Indian ventilator is being made for only Rs 2.5 lakh."
He said, "There is a huge shortage of doctors and paramedical staff in India. There are only 8 doctors per 1000 population. This deficiency cannot be filled at once. However, the government is rapidly opening hospitals and medical colleges. Despite this, the crisis of doctor-staff will continue according to the population and geographical conditions. In such a situation, there is a need to connect the medical system with technology."
--IANS
amita/sha
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)